MaxCyte, Inc. (AIM:MXCT)
152.00
-8.00 (-5.00%)
Inactive · Last trade price on Jun 25, 2025
MaxCyte Employees
MaxCyte had 114 employees as of December 31, 2024. The number of employees decreased by 29 or -20.28% compared to the previous year.
Employees
114
Change (1Y)
-29
Growth (1Y)
-20.28%
Revenue / Employee
255.79K GBP
Profits / Employee
-283.73K GBP
Market Cap
161.75M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 114 | -29 | -20.28% |
Dec 31, 2023 | 143 | 18 | 14.40% |
Dec 31, 2022 | 125 | 41 | 48.81% |
Dec 31, 2021 | 84 | 19 | 29.23% |
Dec 31, 2019 | 65 | 33 | 103.13% |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
MaxCyte News
- 18 days ago - MaxCyte revises 2025 core revenue guidance to $29.5M-$32.5M amid customer program consolidation - Seeking Alpha
- 18 days ago - MaxCyte, Inc. (MXCT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - MaxCyte (MXCT) Q2 Revenue Drops 18% - The Motley Fool
- 19 days ago - MaxCyte GAAP EPS of -$0.12 misses by $0.02, revenue of $8.5M misses by $1.02M - Seeking Alpha
- 21 days ago - MaxCyte Signs Platform License Agreement with Adicet Bio - GlobeNewsWire
- 25 days ago - MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline - GlobeNewsWire
- 6 weeks ago - MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 7 weeks ago - PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire